In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.

Critics argue that NIH directors should have term limits. Others say leadership continuity matters. Who's right?

The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.

As the risk of measles mounts, health care workers face an unusual challenge: Many don't know what it looks like.

The MAHA movement’s embrace of unorthodox therapies has deep roots in U.S. history, says law professor Lewis Grossman.

No wonder the European Marine Energy Center, one of the world’s leading agencies for developing and testing wave and tidal power technologies, chose to set up shop here; the nonprofit agency hosts ...

The elderly woman was sprawled on her back in the dirt, head resting to one side, elbows bent as though she was about to prop herself up. Dead three months now, her face was no longer recognizable.

One bluebird day in 2021, employees of Fortem Technologies traveled to a flat piece of Utah desert. The land was a good spot to try the company’s new innovation: an attachment for the DroneHunter — ...

In June 2015, Jeffrey Thelen’s parents noticed their son was experiencing problems with his memory. In the subsequent years, he would get lost driving to his childhood home, forget his cat had died, ...

A skin condition tied to delusions is posing a riddle for doctors: What to do when a diagnosis causes offense?

Growing up in Teaneck, New Jersey, with a brother who had severe intellectual disabilities, Linda Birnbaum developed an interest in the human brain. She was a formidable child: In 1961, as a teenager, ...

In July 2012, a renegade American businessman, Russ George, took a ship off the coast of British Columbia and dumped 100 tons of iron sulfate dust into the Pacific Ocean. He had unilaterally, and some ...